Irma Bagdoniene: Statin Intolerance – Challenges and Solutions
Irma Bagdoniene, Cardiologist Specializing in Prevention & Lipidology, shared on LinkedIn:
“Statin intolerance: a frequent clinical challenge, but far from a dead end.
True, confirmed statin intolerance with myopathy and CK elevation occurs in about 5% of patients reporting symptoms. Many are actually experiencing the well-documented nocebo effect.
For us, this does not mean stopping therapy. It means adapting our approach.
Most patients labeled ‘intolerant’ do well after switching to another statin (for example, hydrophilic rosuvastatin) or trying low-dose, alternate-day dosing.
For those truly intolerant, therapeutic options remain robust and effective:
• Ezetimibe lowers LDL-C by 15–20%
• Bempedoic acid reduces LDL-C by 15–25% without muscle-related symptoms
• PCSK9 inhibitors provide a powerful 50–60% LDL-C reduction
• Inclisiran, with just twice-yearly dosing, delivers sustained ~60% LDL-C lowering
The CLEAR-Outcomes trial also highlighted that in statin-intolerant patients, hsCRP may predict cardiovascular risk even better than LDL-C.
The take-home message: stopping lipid-lowering therapy should be avoided wherever possible. Re-challenge, switch agents, or refer to a lipid specialist — but never leave high-risk patients unprotected. •
A highly recommended statement on this from the National Lipid Association.”
Stay with Hemostasis Today to explore more from Irma Bagdoniene.
-
Jun 27, 2026, 01:31Alessio De Rose: Addressing Micronutrient Deficiencies in the Era of GLP-1 Receptor Agonists
-
Jun 27, 2026, 01:21Michelle Sámano Sánchez: Exploring Vitamin C as an Adjunct Therapy for Anemia in Hemodialysis
-
Jun 27, 2026, 01:08Ana Raquel Gotine: The First Pragmatic Clinical Trial on MNPs and Childhood Anemia in Mozambique
-
Jun 27, 2026, 00:56Sherif Badawy: Reflecting on My Time with ASH CRTI
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?